Market News & Trends
Unilife Introduces World's First Instant Patch Pump for Insulin
York, PA. – July 29, 2015. Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer, manufacturer and supplier of injectable drug delivery…
Xcelience Makes Structured Cash Investment in Powdersize
TAMPA, FLORIDA (July 31, 2015) – Xcelience, a contract development and manufacturing organization (CDMO), recently announced that it has made a structured cash investment in…
Celgene to Acquire Receptos, Advances Leadership in Immune-Inflammatory Diseases
Celgene Corporation and Receptos, Inc. recently announced the signing of a definitive agreement in which Celgene has agreed to acquire Receptos. Under the terms of…
Actinium Advances Iomab-B Towards Phase III
Actinium Pharmaceuticals, Inc., a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, recently announced it has submitted a request for…
CANbridge Acquires License for Apogenix’s Onco-Immunotherapy
CANbridge Life Sciences, a biopharmaceutical company focused on developing Western drug candidates in China and North Asia, has entered into an exclusive license agreement with…
AnaptysBio Secures $40-Million Financing
AnaptysBio, Inc., a leader in the discovery and development of therapeutic antibodies for inflammation and immuno-oncology, recently announced the completion of an oversubscribed $40MM Series…
Quotient Clinical Announces Expansion of Pharmaceutical Sciences capacity
Quotient Clinical, the Translational Pharmaceutics® Company, has announced a significant expansion of its pharmaceutical sciences capabilities, doubling capacity through the acquisition of a second GMP…
Cristal Therapeutics & PX Biosolutions to Develop Innovative Vaccines
Cristal Therapeutics, a privately-held life sciences company developing innovative products against cancer and other diseases, by using its patented nanotechnology platforms, recently announced the start…
Pharma, Medical & Biotech Global Trend Report
Mergermarket has released its Global Pharma, Medical & Biotech (PMB) trend report for the first half (H1) of 2015. Take a look at the…
Vetter Launches Vetter-Ject® - A New Syringe Closure System for Highly Sensitive Compounds
Vetter recently announced the release of Vetter-Ject®, a novel closure system for prefilled syringes. By this closure part a baked-in siliconization of an integrated needle…
CiMaas & PharmaCell BV Enter Collaborative Agreement
CiMaas BV, a company developing cellular immunotherapy for cancer, and PharmaCell BV, a leading Contract Manufacturing Organization for Cellular Therapies and Regenerative Medicine in Europe,…
EyeGate Signs Licensing Agreement With Valeant Pharmaceuticals
Eyegate Pharmaceuticals, Inc., a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, today…
Cleave Biosciences Receives Orphan Designation From FDA
Cleave Biosciences recently announced that its lead drug candidate, CB-5083, has been granted Orphan Drug Designation by the U.S. Food and Drug Administration (FDA) for…
Celsus Therapeutics Buys Volution Immuno Pharma; Combined Company to be Renamed
Celsus Therapeutics and Volution Immuno Pharmaceuticals SA recently announced that they have entered into a Definitive Exchange Agreement, pursuant to which privately-held Volution Immuno Pharmaceuticals…
Allegro Ophthalmics Announces Positive Topline Results From Phase II Trial
Allegro Ophthalmics, LLC, recently announced that the Phase II clinical trial of Luminate® (ALG-1001) in patients with vitreomacular traction (VMT) or vitreomacular adhesion (VMA) met…
Genentech's Investigational Immunotherapy Atezolizumab Shrank Tumors in Pivotal Study
Genentech, a member of the Roche Group recently announced that in the IMvigor 210 study, the investigational cancer immunotherapy atezolizumab (MPDL3280A; anti-PDL1) shrank tumors (objective…
Catalent Biologics Adds New Technology Platform
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that…
Foster Polymer Copolymer for Medical Mandrels & Release Films
Foster Polymer Distribution, a business unit of Foster Corporation specializing in the distribution of medical polymers and additives, announces their official partnership with Mitsui Chemicals…
Celgene & Juno Announce 10-Year Collaboration to Advance Potentially Groundbreaking Immunotherapies
Celgene Corporation (Nasdaq:CELG) and Juno Therapeutics, Inc. (Nasdaq:JUNO) announced today a global collaboration for the development and commercialization of immunotherapies. The two companies will leverage…
Leti & Eight Partners in BIOCAPAN Project Working On Diabetes Treatment to Replace Injections
An international research consortium coordinated by CEA-Leti announced the launch of BIOCAPAN, a research project funded by the European Commission aiming at developing an innovative…
